molecular function |
| GO:0005125 | | cytokine activity | | Functions to control the survival, growth, differentiation and effector function of tissues and cells. |
| GO:0005126 | | cytokine receptor binding | | Interacting selectively and non-covalently with a cytokine receptor. |
| GO:0008083 | | growth factor activity | | The function that stimulates a cell to grow or proliferate. Most growth factors have other actions besides the induction of cell growth or proliferation. |
| GO:0005136 | | interleukin-4 receptor binding | | Interacting selectively and non-covalently with the interleukin-4 receptor. |
| GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
biological process |
| GO:0042113 | | B cell activation | | The change in morphology and behavior of a mature or immature B cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific. |
| GO:0031296 | | B cell costimulation | | The process of providing, via surface-bound receptor-ligand pairs, a second, antigen-independent, signal in addition to that provided by the B cell receptor to augment B cell activation. |
| GO:0030183 | | B cell differentiation | | The process in which a precursor cell type acquires the specialized features of a B cell. A B cell is a lymphocyte of B lineage with the phenotype CD19-positive and capable of B cell mediated immunity. |
| GO:0002296 | | T-helper 1 cell lineage commitment | | The process in which a CD4-positive, alpha-beta T cell becomes committed to becoming a T-helper 1 cell, a CD4-positive, alpha-beta T cell specialized to promote immunological processes often associated with resistance to intracellular bacteria, fungi, and protozoa, and pathological conditions such as arthritis. |
| GO:0035745 | | T-helper 2 cell cytokine production | | Any process that contributes to cytokine production by a T-helper 2 cell. |
| GO:0045064 | | T-helper 2 cell differentiation | | The process in which a relatively unspecialized T cell acquires specialized features of a T-helper 2 (Th2) cell. A Th2 cell is a CD4-positive, alpha-beta T cell that has the phenotype GATA-3-positive and produces interleukin-4. |
| GO:0006968 | | cellular defense response | | A defense response that is mediated by cells. |
| GO:0071288 | | cellular response to mercury ion | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mercury ion stimulus. |
| GO:0006935 | | chemotaxis | | The directed movement of a motile cell or organism, or the directed growth of a cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis). |
| GO:0008203 | | cholesterol metabolic process | | The chemical reactions and pathways involving cholesterol, cholest-5-en-3 beta-ol, the principal sterol of vertebrates and the precursor of many steroids, including bile acids and steroid hormones. It is a component of the plasma membrane lipid bilayer and of plasma lipoproteins and can be found in all animal tissues. |
| GO:0045189 | | connective tissue growth factor biosynthetic process | | The chemical reactions and pathways resulting in the formation of CTGF, produced by human umbilical vein endothelial cells and by skin fibroblasts after activation with TGF-beta. |
| GO:0042832 | | defense response to protozoan | | Reactions triggered in response to the presence of a protozoan that act to protect the cell or organism. |
| GO:0097028 | | dendritic cell differentiation | | The process in which a precursor cell type acquires the specialized features of a dendritic cell. A dendritic cell is a leukocyte of dendritic lineage specialized in the uptake, processing, and transport of antigens to lymph nodes for the purpose of stimulating an immune response via T cell activation. |
| GO:0097192 | | extrinsic apoptotic signaling pathway in absence of ligand | | A series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with withdrawal of a ligand from a cell surface receptor, and ends when the execution phase of apoptosis is triggered. |
| GO:0007565 | | female pregnancy | | The set of physiological processes that allow an embryo or foetus to develop within the body of a female animal. It covers the time from fertilization of a female ovum by a male spermatozoon until birth. |
| GO:0006955 | | immune response | | Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat. |
| GO:0002227 | | innate immune response in mucosa | | Any process of the innate immune response that takes place in the mucosal tissues. |
| GO:0001774 | | microglial cell activation | | The change in morphology and behavior of a microglial cell resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor. |
| GO:0043011 | | myeloid dendritic cell differentiation | | The process in which a monocyte acquires the specialized features of a dendritic cell, an immunocompetent cell of the lymphoid and hemopoietic systems and skin. |
| GO:0050868 | | negative regulation of T cell activation | | Any process that stops, prevents, or reduces the frequency, rate or extent of T cell activation. |
| GO:2000320 | | negative regulation of T-helper 17 cell differentiation | | Any process that stops, prevents or reduces the frequency, rate or extent of T-helper 17 cell differentiation. |
| GO:0002674 | | negative regulation of acute inflammatory response | | Any process that stops, prevents, or reduces the frequency, rate, or extent of an acute inflammatory response. |
| GO:0043066 | | negative regulation of apoptotic process | | Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process. |
| GO:0002677 | | negative regulation of chronic inflammatory response | | Any process that stops, prevents, or reduces the frequency, rate, or extent of a chronic inflammatory response. |
| GO:1903660 | | negative regulation of complement-dependent cytotoxicity | | Any process that stops, prevents or reduces the frequency, rate or extent of complement-dependent cytotoxicity. |
| GO:2000352 | | negative regulation of endothelial cell apoptotic process | | Any process that stops, prevents or reduces the frequency, rate or extent of endothelial cell apoptotic process. |
| GO:0010633 | | negative regulation of epithelial cell migration | | Any process that stops, prevents, or reduces the frequency, rate or extent of epithelial cell migration. |
| GO:2001237 | | negative regulation of extrinsic apoptotic signaling pathway | | Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway. |
| GO:0043031 | | negative regulation of macrophage activation | | Any process that stops, prevents, or reduces the frequency, rate or extent of macrophage activation. |
| GO:0045019 | | negative regulation of nitric oxide biosynthetic process | | Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of nitric oxide. |
| GO:0045671 | | negative regulation of osteoclast differentiation | | Any process that stops, prevents, or reduces the frequency, rate or extent of osteoclast differentiation. |
| GO:0045892 | | negative regulation of transcription, DNA-templated | | Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription. |
| GO:0070351 | | negative regulation of white fat cell proliferation | | Any process that stops or decreases the rate or extent of white fat cell proliferation. |
| GO:0050871 | | positive regulation of B cell activation | | Any process that activates or increases the frequency, rate or extent of B cell activation. |
| GO:0030890 | | positive regulation of B cell proliferation | | Any process that activates or increases the rate or extent of B cell proliferation. |
| GO:0045348 | | positive regulation of MHC class II biosynthetic process | | Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of MHC class II. |
| GO:0045582 | | positive regulation of T cell differentiation | | Any process that activates or increases the frequency, rate or extent of T cell differentiation. |
| GO:0042102 | | positive regulation of T cell proliferation | | Any process that activates or increases the rate or extent of T cell proliferation. |
| GO:0042104 | | positive regulation of activated T cell proliferation | | Any process that activates or increases the rate or extent of activated T cell proliferation. |
| GO:0008284 | | positive regulation of cell proliferation | | Any process that activates or increases the rate or extent of cell proliferation. |
| GO:0045080 | | positive regulation of chemokine biosynthetic process | | Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of chemokines. |
| GO:0002230 | | positive regulation of defense response to virus by host | | Any host process that results in the promotion of antiviral immune response mechanisms, thereby limiting viral replication. |
| GO:2000424 | | positive regulation of eosinophil chemotaxis | | Any process that activates or increases the frequency, rate or extent of eosinophil chemotaxis. |
| GO:0002639 | | positive regulation of immunoglobulin production | | Any process that activates or increases the frequency, rate, or extent of immunoglobulin production. |
| GO:0032733 | | positive regulation of interleukin-10 production | | Any process that activates or increases the frequency, rate, or extent of interleukin-10 production. |
| GO:0032736 | | positive regulation of interleukin-13 production | | Any process that activates or increases the frequency, rate, or extent of interleukin-13 production. |
| GO:0048295 | | positive regulation of isotype switching to IgE isotypes | | Any process that activates or increases the frequency, rate or extent of isotype switching to IgE isotypes. |
| GO:0048304 | | positive regulation of isotype switching to IgG isotypes | | Any process that activates or increases the frequency, rate or extent of isotype switching to IgG isotypes. |
| GO:0043306 | | positive regulation of mast cell degranulation | | Any process that activates or increases the frequency, rate or extent of mast cell degranulation. |
| GO:0071677 | | positive regulation of mononuclear cell migration | | Any process that increases the rate, frequency or extent of mononuclear cell migration. Mononuclear cell migration is the movement of a mononuclear cell within or between different tissues and organs of the body. |
| GO:1901741 | | positive regulation of myoblast fusion | | Any process that activates or increases the frequency, rate or extent of myoblast fusion. |
| GO:0050731 | | positive regulation of peptidyl-tyrosine phosphorylation | | Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine. |
| GO:0001934 | | positive regulation of protein phosphorylation | | Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein. |
| GO:0051091 | | positive regulation of sequence-specific DNA binding transcription factor activity | | Any process that activates or increases the frequency, rate or extent of activity of a transcription factor, any factor involved in the initiation or regulation of transcription. |
| GO:0045944 | | positive regulation of transcription from RNA polymerase II promoter | | Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
| GO:0045893 | | positive regulation of transcription, DNA-templated | | Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription. |
| GO:0050776 | | regulation of immune response | | Any process that modulates the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus. |
| GO:0050727 | | regulation of inflammatory response | | Any process that modulates the frequency, rate or extent of the inflammatory response, the immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. |
| GO:0045191 | | regulation of isotype switching | | Any process that modulates the frequency, rate or extent of isotype switching. |
| GO:0042325 | | regulation of phosphorylation | | Any process that modulates the frequency, rate or extent of addition of phosphate groups into a molecule. |
| GO:0010155 | | regulation of proton transport | | Any process that modulates the frequency, rate or extent of proton transport into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
| GO:0034097 | | response to cytokine | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cytokine stimulus. |
| GO:0042493 | | response to drug | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease. |
| GO:0045471 | | response to ethanol | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ethanol stimulus. |
| GO:0007584 | | response to nutrient | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nutrient stimulus. |
| GO:0014070 | | response to organic cyclic compound | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus. |
| GO:0060041 | | retina development in camera-type eye | | The process whose specific outcome is the progression of the retina over time, from its formation to the mature structure. The retina is the innermost layer or coating at the back of the eyeball, which is sensitive to light and in which the optic nerve terminates. |
| GO:0042092 | | type 2 immune response | | An immune response which is associated with resistance to extracellular organisms such as helminths and pathological conditions such as allergy, which is orchestrated by the production of particular cytokines, most notably IL-4, IL-5, IL-10, and IL-13, by any of a variety of cell types including T-helper 2 cells, eosinophils, basophils, mast cells, and nuocytes, resulting in enhanced production of certain antibody isotypes and other effects. |
cellular component |
| GO:0009897 | | external side of plasma membrane | | The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface. |
| GO:0005576 | | extracellular region | | The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. |
| GO:0005615 | | extracellular space | | That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |